FDAEuropean Medicines AgencyFood and Drug Administrationnon-small cell lung cancers
…ology drugs approved by the European Medicines Agency (EMA) and FDA between 2014 and 2024, analysing 128 trials in breast, gastroin…
25articles mentioning funders
28funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: European Medicines Agency ×
European Medicines Agency
This funder is selected. Its supporting articles are shown below.
Articles mentioning European Medicines Agency
25 articles · page 2 of 3European Medicines AgencyUS Food and Drug Administrationcancer treatmentsbreast cancernon-small cell lung cancerNSCLCBCEuroQol GroupAmerican Society of Clinical Oncology
…en 2014 and 2024 by the US Food and Drug Administration and the European Medicines Agency. For each product, we assessed pivotal trials for PRO endpoints…
EMAEuropean Medicines AgencyELAFIBRANORSELADELPAROBETICHOLIC ACIDprimary biliary cholangitisPBCPubMedELFursodeoxycholic acid
…Background and Importance The European Medicines Agency (EMA) has recently approved elafibranor (ELF) for the treatment of p…
European Medicines Agencyurothelial carcinomaNivolumab-CTnivolumabgemcitabine-cisplatinpembrolizumabEV-Pembrolizumabenfortumab vedotinUCgemcitabine
…Background and Importance The European Medicines Agency recently approved new treatments such as enfortumab vedotin plu…
Food and Drug AdministrationEuropean Medicines Agency
… US and Australia, along with the European Medicines Agency and Food and Drug Administration. The expert interviews aimed to validate document selection and…
European Medicines AgencyUS Food and Drug Administrationtype 2 diabeteschronic kidney diseaseSemaglutidetirzepatideliraglutideCagriSemaCardiovascular diseases
…ide are approved by the US Food and Drug Administration and the European Medicines Agency for the treatment of type 2 diabetes mellitus and overweight. C…
EMAEuropean Medicines AgencyEuropean Medicines AgencyUS FDArenal cell carcinomabreast cancercolon cancerhepatocellular carcinomacancertrastuzumab+6 more
…Pathological Complete Response as an endpoint. I still find the EMA (European Medicines Agency) is a bit robust. But the FDA has re…
European Medicines AgencyEMAovarian cancerNiraparib
…ents. One of these is hypomagnesaemia, which is absent from the European Medicines Agency (EMA) Summary of Product Characteristics (SmPC),1 despite being…
European Medicines Agencydextroamphetamineamphetaminecardiovascular complicationspsychiatric comorbiditiesmethamphetamineinjection-related infectionsATLAS4Dependenceopioid agonist treatmentpoor social functioning+1 more
… be presented.Ethics and dissemination The study is approved by European Medicines Agency, Clinical Trial Information System (CTIS). Written informed con…
European Medicines AgencyEMAGiant cell arteritis (GCA)tocilizumabTCZCPP Sud Ouest et Outre Mer IVGCAglucocorticoidsFrench National Agency for Medicines and Health Products Safety—ANSM
…h the Clinical Trials Information System (CTIS) provided by the European Medicines Agency (EMA). The informed consent complies with the ICH GCP guideline…
European Medicines Agencysecondary malignancies of T-cell originCAR T-cell medicines
…Abstract Overview of: European Medicines Agency. CAR T-cell medicines: PRAC identifies risk of secondary malign…
European Medicines Agencybipolar disorderLithiumcariprazine
… been approved by the regional ethical committee N-20220007 and European Medicines Agency. All participants provide written informed consent. The protoco…